Kumar Gunjan, Dash Payal, Nanda Smruti Bhusan, Fareed Mohammad, Karobari Mohmed Isaqali
Department of Public Health Dentistry, Kalinga Institute of Dental Sciences (KIDS), Kalinga Institute of Industrial Technology (KIIT) Deemed to Be University, Bhubaneswar, India.
Mamata Orthodontic Clinic Saheed Nagar, Bhubaneswar, India.
Immun Inflamm Dis. 2025 Sep;13(9):e70253. doi: 10.1002/iid3.70253.
The current systematic review and meta-analysis aims to assess the safety and immunogenicity of the anticaries vaccines currently available.
Electronic searches of PubMed, Scopus, Web of Science and Science Direct were performed. Studies assessing the safety and effectiveness of the anticaries vaccination, including the dose, plasmids, serum IgG and IgA levels after immunization, were included. Studies in which animals were used for anticaries vaccine were also included. Combining more than one trial was done to estimate the pooled intervention effect using the meta-analysis when studies examined the same intervention and outcomes with comparable methods in similar populations. The continuous data was pooled using the inverse variance method, and dichotomous data using the Mantel-Haenszel method.
Out of 4701 records, only 17 publications met the eligibility criteria. Although all studies were assessed as having an overall low risk of bias, certain domains (D3, D5, and D7) exhibited a high risk across most studies. The pooled RR, derived using a random-effects model, was 0.53 (95% CI: 0.46-0.62), indicating a statistically significant 47% reduction in risk across studies.
There is excellent potential for dental caries vaccines to transform oral health in the future. Various vaccines, such as Killed Formalin-treated Donor strain 2 - recombinant Protein Antigen c and anti-CAT-SYIIgY antibodies, have demonstrated prophylactic effects against Streptococcus mutans colonization on teeth. These interventions exhibit a sustained reduction in S. mutans colonization, which may contribute to the prevention of dental caries. A vaccination of this kind would significantly lower tooth decay prevalence and the financial and health costs that go along with it.
本系统评价和荟萃分析旨在评估目前可用的抗龋疫苗的安全性和免疫原性。
对PubMed、Scopus、Web of Science和ScienceDirect进行电子检索。纳入评估抗龋疫苗安全性和有效性的研究,包括免疫后的剂量、质粒、血清IgG和IgA水平。使用动物进行抗龋疫苗研究的也纳入。当研究在相似人群中用可比方法检验相同干预措施和结果时,采用荟萃分析合并多个试验以估计合并干预效应。连续数据采用逆方差法合并,二分数据采用Mantel-Haenszel法合并。
在4701条记录中,只有17篇出版物符合纳入标准。尽管所有研究被评估为总体偏倚风险较低,但某些领域(D3、D5和D7)在大多数研究中显示出高风险。采用随机效应模型得出的合并RR为0.53(95%CI:0.46-0.62),表明各研究间风险在统计学上显著降低了47%。
龋齿疫苗未来在改善口腔健康方面具有巨大潜力。各种疫苗,如福尔马林灭活供体菌株2-重组蛋白抗原c和抗CAT-SYIIgY抗体,已证明对变形链球菌在牙齿上的定植有预防作用。这些干预措施使变形链球菌定植持续减少,这可能有助于预防龋齿。这种疫苗接种将显著降低龋齿患病率以及与之相关的经济和健康成本。